Role of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease

Cites (492)

Items 201–400 of 492

1. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
   Aslam Hayat Anis, Larry David Lynd, Xiaohong Wang · 2001 · PubMed
2. The guanine nucleotide exchange factor CNrasGEF activates Ras in response to cAMP and cGMP
   N. Pham, Ivan B. Cheglakov, Christine Anne Koch, Carmen L. de Hoog, Michael F. Moran, Daniela Rotin · 2000 · Current Biology
3. Beta-adrenergic receptors and their mode of coupling to adenylate cyclase
   Alexander Levitzki · 1986 · Physiological Reviews
4. Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation
   David M. Essayan · 1999 · Biochemical Pharmacology
5. Clenbuterol, a β-Adrenoceptor Agonist, Increases Relative Muscle Strength in Orthopaedic Patients
   C. A. Maltin, Margaret I. Delday, Jennifer S. Watson · 1993 · Clinical Science
6. The Risk of Myocardial Infarction Associated with Inhaled β -Adrenoceptor Agonists
   David H. Au, Rozenn N. Lemaître, Jared Randall Curtis · 2000 · American Journal of Respiratory and Critical Care Medicine
7. Adverse Effects of β-Agonists
   Michael John Abramson, Julia AE Walters, Eugene Haydn Walters · 2003 · American Journal of Respiratory Medicine
8. Calcium release in skinned muscle fibres of the toad by transverse tubule depolarization or by direct stimulation.
   Graham D. Lamb, Dimitrie George Stephenson · 1990 · The Journal of Physiology
9. The Orphan Nuclear Receptor, NOR-1, Is a Target of β-Adrenergic Signaling in Skeletal Muscle
   Michael A. Pearen, James G. Ryall, Megan Maxwell, Naganari Ohkura, Gordon Stuart Lynch, George E.O. Muscat · 2006 · Endocrinology
10. Formoterol
    R A Bartow, Rex N. Brogden · 1998 · Drugs
11. Effect of the β-adrenergic agonist L644,969 on muscle growth, endogenous proteinase activities, and postmortem proteolysis in wether lambs1
    M. Koohmaraie, S. D. Shackelford, N. E. Muggli-Cockett, ROGER T. STONE · 1991 · Journal of Animal Science
12. Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle <i>β</i>-adrenoceptors to induce hypertrophy
    MacLennan, P A, Edwards, R H · 1989 · Biochemical Journal
13. ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes
    Asterios Pantazis Deligiannis, Hans Halvor Björnstad, François Carré, Hein Heidbüchel, Evangelia Joseph Kouidi, Nicole M Panhuyzen-Goedkoop, Fabio Pigozzi, Wilhelm Schänzer, Luc Vanhees, on behalf of the ESC Study Group of Sports Cardiology · 2006 · European Journal of Cardiovascular Prevention & Rehabilitation
14. Drugs and Sport
    Priscilla M. Clarkson, Heather S. Thompson · 1997 · Sports Medicine
15. Abolition of (-)-CGP 12177-evoked cardiostimulation in double ? 1 /? 2 -adrenoceptor knockout mice. Obligatory role of ? 1 -adrenoceptors for putative ? 4 -adrenoceptor pharmacology
    Alberto Julio Kaumann, Stefan Hanns Engelhardt, Lutz Hein, Peter Molenaar, Martin J. Lohse · 2001 · Naunyn-Schmiedeberg s Archives of Pharmacology
16. Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia
    Paola Costelli, Roberta DE TULLIO, Francesco Maria Baccino · 2001 · British Journal of Cancer
17. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway
    Yimlamai, Tossaporn, Dodd, Stephen L., Borst, Stephen E., Park, Sooyeon · 2005 · Journal of Applied Physiology
18. The effect of a growth promoting drug, clenbuterol, on fibre frequency and area in hind limb muscles from young male rats
    C. A. Maltin, Margaret I. Delday, P. J. Reeds · 1986 · Bioscience Reports
19. Clenbuterol
    Irvine D. Prather, DAVID E. BROWN, PERRY NORTH, Judy R. Wilson · 1995 · Medicine & Science in Sports & Exercise
20. Effects of aging and caloric restriction on the gene expression of Foxo1, 3, and 4 (FKHR, FKHRL1, and AFX) in the rat skeletal muscles
    Tatsuo Furuyama, Hitoshi Yamashita, Kazuko Kitayama, Yoshikazu Higami, Isao Shimokawa, Nozomu Mori · 2002 · Microscopy Research and Technique
21. The effect of the β-2-adrenergic agonist clenbuterol or implantation with oestradiol plus trenbolone acetate on protein metabolism in wether lambs
    Ognian Bohorov, PETER J. BUTTERY, J. H. R. D. Correia, John B. Soar · 1987 · British Journal Of Nutrition
22. Functional characteristics of dystrophic skeletal muscle: insights from animal models
    Jon F. Watchko, Terrence L. O’Day, Eric P. Hoffman · 2002 · Journal of Applied Physiology
23. Localization of the Ca2+‐dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscle
    Toshihide Kumamoto, William C. Kleese, Jinyang Cong · 1992 · The Anatomical Record
24. β-adrenergic agonists and hypertrophy of skeletal muscles
    Yong S. Kim, Roberto Daniel Sainz · 1992 · Life Sciences
25. Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes
    Suleiman W. Bahouth · 1991 · Journal of Biological Chemistry
26. Systemic administration of β2‐adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses
    James G. Ryall, Martin N. Sillence, Gordon Stuart Lynch · 2006 · British Journal of Pharmacology
27. Characterization of β1- and β2-adrenoceptors in rat skeletal muscles
    Yong S. Kim, Roberto Daniel Sainz, Peter C. M. Molenaar · 1991 · Biochemical Pharmacology
28. Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles
    Richard J. Zeman, R. Ludemann, Joseph D. Etlinger · 1987 · American Journal of Physiology-Endocrinology and Metabolism
29. Regulated ubiquitination of proteins in GPCR-initiated signaling pathways
    Richard J.H. Wojcikiewicz · 2003 · Trends in Pharmacological Sciences
30. β2-Adrenergic Receptors Potentiate Glucocorticoid Receptor Transactivation via G Proteinβγ -Subunits and the Phosphoinositide 3-Kinase Pathway
    Peer Schmidt, Florian Holsboer, Dietmar Spengler · 2001 · Molecular Endocrinology
31. Differential activation of alpha 1- and alpha 2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation.
    Mitsumasa Ohyanagi, James E. Faber, Kazuhiko Nishigaki · 1991 · Circulation Research
32. Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat
    L. Stevens, Carole Ricart-Firinga, Bärbel Gohlsch, Bruno Bastide, Yvonne Mounier, Dirk Pette · 2000 · American Journal of Physiology-Cell Physiology
33. Molecular Characterization of an Anchor Protein (AKAPCE) That Binds the RI Subunit (RCE) of Type I Protein Kinase A from Caenorhabditis elegans
    Robert G. Angelo, Charles S. Rubin · 1998 · Journal of Biological Chemistry
34. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain.
    Luis Salleras, A Domínguez, Enrique Mata · 1995 · PubMed
35. β2‐Agonist administration reverses muscle wasting and improves muscle function in aged rats
    James G. Ryall, David R. Plant, Paul Gregorevic, Martin N. Sillence, Gordon Stuart Lynch · 2003 · The Journal of Physiology
36. Phosphorylation of β-Arrestin2 Regulates Its Function in Internalization of β2-Adrenergic Receptors
    Fang‐Tsyr Lin, Wei R. Chen, Sudha K. Shenoy · 2002 · Biochemistry
37. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties
    Stefan Klotz, Alessandro Barbone, Steven R. Reiken · 2005 · Journal of the American College of Cardiology
38. Mitochondrial dysfunction and neuromuscular disease
    Rachel A. Nardin, Donald R. Johns · 2001 · Muscle & Nerve
39. Cloning and Characterization of A-kinase Anchor Protein 100 (AKAP100)
    Shirley McCartney, Brian M. Little, Lorene K. Langeberg, John D. Scott · 1995 · Journal of Biological Chemistry
40. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features
    Kit Wong, Kenneth R. Boheler, Jill E. Bishop · 1998 · Cardiovascular Research
41. β2-Adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury
    Felice Beitzel, Paul Gregorevic, James G. Ryall, David R. Plant, Martin N. Sillence, Gordon Stuart Lynch · 2004 · Journal of Applied Physiology
42. (−)-CGP 12177 Causes Cardiostimulation and Binds to Cardiac Putative β4-Adrenoceptors in Both Wild-Type and β3-Adrenoceptor Knockout Mice
    Alberto Julio Kaumann, Frédéric Preitner, Doreen Sarsero, Peter Molenaar, Jean‐Pierre Revelli, Jean Paul Giacobino · 1998 · Molecular Pharmacology
43. Muscle Metabolism and Real-Time Ultrasound Measurement of Muscle and Subcutaneous Adipose Tissue Growth in Lambs Fed Diets Containing a Beta-Agonist1
    P.L. Hamby, James R. Stouffer, Stephen Brent Smith · 1986 · Journal of Animal Science
44. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle
    Luiz Carlos Carvalho Navegantes, Neusa M. Z. Resano, Renato H. Migliorini, Ísis do Carmo Kettelhut · 2000 · American Journal of Physiology-Endocrinology and Metabolism
45. Effects of Adrenergic Activators and Inhibitors on the Skeletal Muscles
    W. C. Bowman · 1981 · Handbook of experimental pharmacology
46. Phospholamban mediates the beta-adrenergic-enhanced Ca2+ uptake in mammalian ventricular myocytes
    James S.K. Sham, L. R. Jones, Martin Morad · 1991 · American Journal of Physiology-Heart and Circulatory Physiology
47. Decreased myofibrillar protein breakdown following treatment with clenbuterol
    Daniel W. Benson, Teri Foley‐Nelson, William T. Chance, Fusheng Zhang, J. Howard James, J E Fischer · 1991 · Journal of Surgical Research
48. Changes in tissue blood flow and β‐receptor density of skeletal muscle in rats treated with the β2‐adrenoceptor agonist clenbuterol
    Nancy Jane Rothwell, Michael J. Stock, Deepak K. Sudera · 1987 · British Journal of Pharmacology
49. Enhanced mtDNA repair capacity protects pulmonary artery endothelial cells from oxidant-mediated death
    Allison W. Dobson, Valentina I. Grishko, Susan P. LeDoux, Mark R. Kelley, Glenn L. Wilson, Mark N. Gillespie · 2002 · American Journal of Physiology-Lung Cellular and Molecular Physiology
50. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle
    STEPHEN L. DODD, Scott K. Powers, Ioannis S. Vrabas · 1996 · Medicine & Science in Sports & Exercise
51. Pilot trial of albuterol in facioscapulohumeral muscular dystrophy
    J. T. Kissel, M. P. McDermott, R. Natarajan, Jerry R. Mendell, S. Pandya, Wendy M. King, Robert C. Griggs, Rabi Tawil, The FSH-DY Group* · 1998 · Neurology
52. Reduced Calcium-Dependent Proteinase Activity in Cimaterol-Induced Muscle Hypertrophy in Lambs
    S.-Y. Wang, D. H. Beermann · 1988 · Journal of Animal Science
53. The Abuse of Doping Agents in Competing Body Builders in Flanders (1988-1993)
    Frans T. Delbeke, N. Desmet, M. Debackere · 1995 · International Journal of Sports Medicine
54. The GRK4 Subfamily of G Protein-coupled Receptor Kinases
    Richard T. Premont, Alexander D. Macrae, Samuel A. J. R. Aparicio, Humphrey E. Kendall, Jeffrey E. Welch, Robert J. Lefkowitz · 1999 · Journal of Biological Chemistry
55. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats
    Noel D. Duncan, David A. Williams, Gordon Stuart Lynch · 2000 · Clinical Science
56. Effects of Cimaterol on Rabbit Growth and Myofibrillar Protein Degradation and on Calcium-Dependent Proteinase and Calpastatin Activities in Skeletal Muscle
    N.E. Forsberg, M.A. Ilian, A. Ali-Bar, P. R. Cheeke, Nancy B. Wehr · 1989 · Journal of Animal Science
57. Myotoxic effects of clenbuterol in the rat heart and soleus muscle
    Jatin G. Burniston, Yeelan Ng, William Andrew Clark · 2002 · Journal of Applied Physiology
58. Adrenergic control of protein metabolism in skeletal muscle
    Luiz Carlos Carvalho Navegantes, Renato H. Migliorini, Ísis do Carmo Kettelhut · 2002 · Current Opinion in Clinical Nutrition & Metabolic Care
59. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning.
    V Sporano, Laura Grasso, Mauro Esposito · 1998 · PubMed
60. Perioperative use of α2-adrenoceptor agonists and the cardiac patient
    Riku Aantaa, Jouko R. Jalonen · 2006 · European Journal of Anaesthesiology
61. Influence of oxygen precipitation along dislocations on the strength of silicon crystals
    Ichiro Yonenaga, Kôji Sumino · 1996 · Journal of Applied Physics
62. Adipose tissue cellularity and muscle growth in young steers fed the beta-adrenergic agonist clenbuterol for 50 days and after 78 days of withdrawal.
    Ann M Schiavetta, Matthew Miller, D. K. Lunt · 1990 · Journal of Animal Science
63. β2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle
    Jatin G. Burniston, Lip‐Bun Tan, David F. Goldspink · 2005 · Journal of Applied Physiology
64. Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline
    Erlend O. Brennesvik, Chariklia Ktori, Jérôme Ruzzin, Einar Jebens, Peter Robin Shepherd, Jørgen Jensen · 2005 · Cellular Signalling
65. A review of the toxicology of salbutamol (albuterol)
    Susan E. Libretto · 1994 · Archives of Toxicology
66. Effect of β-agonists on expression of calpain and calpastatin activity in skeletal muscle
    RONALD G. BARDSLEY, S.M.J. Allock, S.M.J. Allcock · 1992 · Biochimie
67. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue
    Leah J. Harcourt, Jonathan D. Schertzer, James G. Ryall, Gordon Stuart Lynch · 2006 · Neuromuscular Disorders
68. Evidence that glucocorticoid response elements in the 5′-noncoding region of the hamster β2-adrenergic receptor gene are obligate for glucocoticoid regulation of receptor mRNA levels
    Craig C. Malbon, John R. Hadcock · 1988 · Biochemical and Biophysical Research Communications
69. Control of calcium release and the effect of ryanodine in skinned muscle fibres of the toad.
    Graham D. Lamb, Dimitrie George Stephenson · 1990 · The Journal of Physiology
70. Skeletal Muscle Protein Synthesis and Growth Hormone Secretion in Young Lambs Treated with Clenbuterol
    M. C. Claeys, Don R Mulvaney, F. D. McCarthy · 1989 · Journal of Animal Science
71. Update on current concepts of the molecular basis of β2-adrenergic receptor signaling
    Stephen B. Liggett · 2002 · Journal of Allergy and Clinical Immunology
72. Type V, but not Type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity
    Isabelle Espinasse, Vadim Iourgenko, Nicole Defer, Françoise Samson, Jacques Hanoune, Jean-Jacques Mercadier · 1995 · Journal of Molecular and Cellular Cardiology
73. Beta-adrenergic receptor distribution among muscle fiber types and resistance arterioles of white, red, and intermediate skeletal muscle.
    Wade H. Martin, Sidney S. Murphree, Jeffrey E. Saffitz · 1989 · Circulation Research
74. Differential adrenergic regulation of the gene expression of the β-adrenoceptor subtypes β1, β2 and β3 in brown adipocytes
    Tore Bengtsson, Barbara Cannon, Jan Nedergaard · 2000 · Biochemical Journal
75. Ractopamine induces differential gene expression in porcine skeletal muscles1
    Andrea Michelle Gunawan, Brian Thomas Richert, Allan Paul Schinckel, Alan L. Grant, David Edwin Gerrard · 2007 · Journal of Animal Science
76. β2-Agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol
    James G. Ryall, Paul Gregorevic, David R. Plant, Martin N. Sillence, Gordon Stuart Lynch · 2002 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
77. Heterotrimeric G Proteins
    Bernhard Hampoelz, Juergen A. Knoblich · 2004 · Cell
78. Search for new cyclic AMP‐binding proteins
    Sarah Dremier, Reidun Kopperud, Stein Ove Døskeland, J.E. Dumont, Carine Maenhaut · 2003 · FEBS Letters
79. The mAKAP signaling complex: Integration of cAMP, calcium, and MAP kinase signaling pathways
    Kimberly L. Dodge‐Kafka, Michael S. Kapiloff · 2006 · European Journal of Cell Biology
80. The action of the β-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles
    C. A. Maltin, S M Hay, Margaret I. Delday, Gerald E. Lobley, P. J. Reeds · 1989 · Biochemical Journal
81. Clenbuterol, a beta agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms
    C. A. Maltin, S. M. Hay, Margaret I. Delday, F. G. Walton Smith, G. E. Lobley, P. J. Reeds · 1987 · Bioscience Reports
82. Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats
    W J Carter, A.Q. Dang, Fred H. Faas · 1991 · Metabolism
83. Formation of Inactive cAMP-saturated Holoenzyme of cAMP-dependent Protein Kinase under Physiological Conditions
    Reidun Kopperud, Anne Elisabeth Christensen, Endre Kjærland · 2002 · Journal of Biological Chemistry
84. Targeting of Protein Kinase A by Muscle A Kinase-anchoring Protein (mAKAP) Regulates Phosphorylation and Function of the Skeletal Muscle Ryanodine Receptor
    Mary Louise Ruehr, Mary A. Russell, Donald G. Ferguson, Manju Bhat, Jianjie Ma, Derek S. Damron, John D. Scott, Meredith Bond · 2003 · Journal of Biological Chemistry
85. Changes in skeletal muscle gene expression following clenbuterol administration
    Diane Moody Spurlock, T. G. McDaneld, Lauren M. McIntyre · 2006 · BMC Genomics
86. Type 5 Phosphodiesterase Inhibitors in the Treatment of Erectile Dysfunction and Cardiovascular Disease
    Gautham Ravipati, John Arthur McClung, Wilbert S. Aronow · 2007 · Cardiology in Review
87. Metabolic and hormonal interactions between muscle and adipose tissue
    Eva Tomás, Meghan Kelly, Xiaoqin Xiang, Tsu‐Shuen Tsao, Charlotte Keller, Pernille Keller, Zhijun Luo, Harvey F. Lodish, Asish K. Saha, Roger H. Unger et al. · 2004 · Proceedings of The Nutrition Society
88. Catecholamines inhibit Ca2+-dependent proteolysis in rat skeletal muscle through β2-adrenoceptors and cAMP
    Luiz Carlos Carvalho Navegantes, Neusa M. Z. Resano, Renato H. Migliorini, Ísis do Carmo Kettelhut · 2001 · American Journal of Physiology-Endocrinology and Metabolism
89. GiActivator Region of α2A-Adrenergic Receptors: Distinct Basic Residues Mediate Giversus GsActivation
    Susan M. Wade, William K. Lim, Keng-Li Lan · 1999 · Molecular Pharmacology
90. Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle
    Gopal K. R. Soppa, Ryszard Tomasz Smolenski, Najma Latif · 2004 · American Journal of Physiology-Heart and Circulatory Physiology
91. Alternative splicing generates two isoforms of the β3‐adrenoceptor which are differentially expressed in mouse tissues
    Bronwyn A. Evans, Maria Papaioannou, Stephanie Hamilton · 1999 · British Journal of Pharmacology
92. Extracellular signal-regulated kinase pathway is differentially involved in β-agonist-induced hypertrophy in slow and fast muscles
    Hao Shi, Caiyun Zeng, Aymeric Ricome, Kevin Hannon, Alan L. Grant, David Edwin Gerrard · 2006 · American Journal of Physiology-Cell Physiology
93. Cytokines as Mediators and Targets for Cancer Cachexia
    Josep María Adell Argilés, Sı́lvia Busquets, Francisco Javier López-Soriano · 2006 · Cancer treatment and research
94. Direct Binding of the β1 Adrenergic Receptor to the Cyclic AMP-Dependent Guanine Nucleotide Exchange Factor CNrasGEF Leads to Ras Activation
    Youngshil Pak, Nam Pham, Daniela Rotin · 2002 · Molecular and Cellular Biology
95. Clenbuterol, a β2-agonist, retards atrophy in denervated muscles
    Richard J. Zeman, R. Ludemann, Joseph D. Etlinger · 1987 · American Journal of Physiology-Legacy Content
96. Exercise performance in 6-to-11-year-old boys with Duchenne muscular dystrophy.
    Ronald Sockolov, Billy Irwin, RH Dressendorfer · 1977 · PubMed
97. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat
    P. Rajab, John Fox, Samina S. Riaz · 2000 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
98. Regulation of Arrestin-3 Phosphorylation by Casein Kinase II
    You‐Me Kim, Larry S. Barak, Marc G. Caron · 2002 · Journal of Biological Chemistry
99. The positive inotropic effect of epinephrine on skeletal muscle: A brief review
    Jay H. Williams, William Stephen Barnes · 1989 · Muscle & Nerve
100. Catabolic mediators as targets for cancer cachexia
     Josep María Adell Argilés, Rodrigo Moore‐Carrasco, Sı́lvia Busquets, Francisco Javier López-Soriano · 2003 · Drug Discovery Today
101. Effects of β2-agonist administration and exercise on contractile activation of skeletal muscle fibers
     Gordon Stuart Lynch, Alan Hayes, Síun P. Campbell‐O'Sullivan, David A. Williams · 1996 · Journal of Applied Physiology
102. Protein synthesis, amino acid uptake, and pools during isoproterenol-induced hypertrophy of the rat heart and tibialis muscle
     Yves Deshaies, Joan Willemot, JACQUES LEBLANC · 1981 · Canadian Journal of Physiology and Pharmacology
103. Pilot trial of albuterol in Duchenne and Becker muscular dystrophy
     Eileen Greenan Fowler, M C Graves, Glenn T. Wetzel · 2004 · Neurology
104. Calcium microdomains and gene expression in neurons and skeletal muscle cells
     M. Angélica Carrasco, Cecilia Hidalgo · 2006 · Cell Calcium
105. The action of the β-agonist clenbuterol on protein and energy metabolism in fattening wether lambs
     J.C. MacRae, Pat A. Skene, Alexmary Connell · 1988 · British Journal Of Nutrition
106. Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle
     Philip Babij, Frank W. Booth · 1988 · American Journal of Physiology-Cell Physiology
107. Nutrition, Development and Efficacy of Growth Modifiers in Livestock Species
     Alan W. Bell, Dale Elton Bauman, D. H. Beermann · 1998 · Journal of Nutrition
108. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats
     William J. Carter, Mary E. Lynch · 1994 · Metabolism
109. Putative β4‐adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (−)‐[3H]‐CGP 12177 binding
     Doreen Sarsero, Peter C. M. Molenaar, Alberto Julio Kaumann · 1999 · British Journal of Pharmacology
110. Interaction between clenbuterol and run training: effects on exercise performance and MLC isoform content
     Christopher Paul Ingalls, W. S. Barnes, Stephen Brent Smith · 1996 · Journal of Applied Physiology
111. Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle
     Timothy J. Bloom · 2002 · Canadian Journal of Physiology and Pharmacology
112. Chronic clenbuterol administration negatively alters cardiac function
     Margaret M. Sleeper, Charles F. Kearns, Kenneth Harrington McKeever · 2002 · Medicine & Science in Sports & Exercise
113. Mouse β3a‐ and β3b‐adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways
     Dana S. Hutchinson, Tore Bengtsson, Bronwyn A. Evans, Roger J. Summers · 2002 · British Journal of Pharmacology
114. Attenuation of Age-Related Muscle Wasting and Weakness in Rats After Formoterol Treatment: Therapeutic Implications for Sarcopenia
     James G. Ryall, Jonathan D. Schertzer, Gordon Stuart Lynch · 2007 · The Journals of Gerontology Series A
115. β‐Adrenergic potentiation of E–C coupling increases force in rat skeletal muscle
     Simeon P. Cairns, Angela Fay Dulhunty · 1993 · Muscle & Nerve
116. Myosin isoform transitions in regeneration of fast and slow muscles during postnatal development of the rat
     Anne d’Albis, René Couteaux, Chantal Janmot · 1989 · Developmental Biology
117. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
     Glen Apseloff, Beverly E. Girten, M Walker · 1993 · Journal of Pharmacology and Experimental Therapeutics
118. Beta 1- and beta 2-adrenergic receptor expression in differentiating 3T3-L1 cells. Independent regulation at the level of mRNA.
     S J Guest, John R. Hadcock, David C. Watkins · 1990 · Journal of Biological Chemistry
119. A standardized method for the evaluation of respiratory muscle endurance in patients with Duchenne muscular dystrophy
     Stéfan Matecki, Nathalie Topin, Maurice Hayot, François Rivier, Bernard Échenne, CHRISTIAN G. PREFAUT, Michèle Ramonatxo · 2001 · Neuromuscular Disorders
120. Effect of continuous and intermittent clenbuterol feeding on rat growth rate and muscle
     Mary Ann McElligott, Albert Barreto, Chaung Lee-Yuh · 1989 · Comparative Biochemistry and Physiology Part C Comparative Pharmacology
121. Mofification of body composition by clenbuterol in normal and dystrophic (mdx) mice
     Nancy Jane Rothwell, Michael J. Stock · 1985 · Bioscience Reports
122. Duality of G protein-coupled mechanisms for β-adrenergic activation of NKCC activity in skeletal muscle
     Aidar R. Gosmanov, Jennifer A. Wong, Donald B. Thomason · 2002 · American Journal of Physiology-Cell Physiology
123. Prostaglandin E1 Activation of Heart cAMP-dependent Protein Kinase: Apparent Dissociation of Protein Kinase Activation from Increases in Phosphorylase Activity and Contractile Force
     Stanley L. Keely · 1979 · Molecular Pharmacology
124. Clenbuterol and Anabolic Steroids
     Daniel R. Goldstein, Thomas E. Dobbs, BARBARA KRULL · 1998 · Southern Medical Journal
125. Effect of clenbuterol on normal and denervated muscle growth and contractility
     E.T. Agbenyega, Anthony C. Wareham · 1990 · Muscle & Nerve
126. Effects of β2-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat
     Carole Ricart-Firinga, Laurence Stevens, Marie‐Hélène Canu · 2000 · American Journal of Physiology-Cell Physiology
127. Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70S6kin muscle showing clenbuterol-induced anabolism
     Alan A. Sneddon, Margaret I. Delday, J. Steven, C. A. Maltin · 2001 · American Journal of Physiology-Endocrinology and Metabolism
128. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats
     Kuangjen D. Chen, Stephen E. Alway · 2000 · Journal of Applied Physiology
129. Myocardial Infarction in a 17-Year-Old Body Builder Using Clenbuterol
     Beata Kierzkowska, Jerzy Stańczyk, Jarosław Damian Kasprzak · 2005 · Circulation Journal
130. SOCS-3 Induces Myoblast Differentiation
     Espen E. Spangenburg · 2005 · Journal of Biological Chemistry
131. Increased muscle strength in paralyzed patients after spinal cord injury: Effect of beta-2 adrenergic agonist
     Joseph F. Signorile, Krešimir Banovac, María Fernanda Lorenzo Gómez, D. Flipse, John F. Caruso, Ilka Lowensteyn · 1995 · Archives of Physical Medicine and Rehabilitation
132. Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on �2-adrenoceptor density in female rats
     Martin N. Sillence, M. L. Matthews, WG Spiers · 1991 · Naunyn-Schmiedeberg s Archives of Pharmacology
133. Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration
     N Moore, G. G. Pegg, Martin N. Sillence · 1994 · American Journal of Physiology-Endocrinology and Metabolism
134. Development of isoproterenol-indueed cardiac hypertrophy
     Paul B. Taylor, Qian� Tang · 1984 · Canadian Journal of Physiology and Pharmacology
135. Effects of terbutaline on force and intracellular calcium in slow‐twitch skeletal muscle fibres of the rat
     Tuyen N. V. Ha, Giuseppe S. Posterino, Martin W. Fryer · 1999 · British Journal of Pharmacology
136. Differential phosphorylation and dephosphorylation of β2‐adrenoceptor sites Ser262 and Ser355,356
     Varsha Iyer, Tuan M. Tran, Estrella A. Foster · 2005 · British Journal of Pharmacology
137. Distinct Sites on G Protein βγ Subunits Regulate Different Effector Functions
     Tooraj Mirshahi, Vivek Mittal, Hailin Zhang · 2002 · Journal of Biological Chemistry
138. Clenbuterol, a beta 2-receptor agonist, reduces net bone loss in denervated hindlimbs
     Richard J. Zeman, Albert O.HG Hirschman, M. L. Hirschman · 1991 · American Journal of Physiology-Endocrinology and Metabolism
139. β2-Agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle
     Jonathan D. Schertzer, David R. Plant, James G. Ryall, Felice Beitzel, Nicole Stupka, Gordon Stuart Lynch · 2004 · American Journal of Physiology-Endocrinology and Metabolism
140. The β2-adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia
     Yuan Shan Zhu, Jochen H.M. Prehn, Carsten Culmsee, Josef Krieglstein · 1999 · Neuroscience
141. Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy
     Richard T. Hinkle, Elizabeth T. Dolan, David B. Cody, Mary Beth Bauer, Robert J. Isfort · 2005 · Muscle & Nerve
142. Are Peroxisome Proliferator-Activated Receptors Involved in Skeletal Muscle Wasting during Experimental Cancer Cachexia? Role of β2-Adrenergic Agonists
     Gemma Fuster, Sı́lvia Busquets, Elisabet Ametller, Mireia Oliván, Vanessa Almendro, Cibely Cristine Fontes de Oliveira, Maite Figueras, Francisco Javier López-Soriano, Josep María Adell Argilés · 2007 · Cancer Research
143. Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol
     Alan Hayes, David A. Williams · 1998 · Journal of the Neurological Sciences
144. PPARδ expression is influenced by muscle activity and induces slow muscle properties in adult rat muscles after somatic gene transfer
     Ida Gjervold Lunde, Merete Ekmark, Zaheer A. Rana, Andrés Buonanno, Kristian Gundersen · 2007 · The Journal of Physiology
145. Differential effects of dexamethasone and clenbuterol on rat growth and on beta2-adrenoceptors in lung and skeletal muscle.
     H Huang, Carlo Gazzola, G. G. Pegg, Martin N. Sillence · 2000 · Journal of Animal Science
146. Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice
     Esther E. Dupont‐Versteegden · 1996 · Journal of Applied Physiology
147. Early metabolic and endocrine effects of perorally administered ß-adrenoceptor agonists in calves
     Juerg W. Blum, Niklaus Flueckiger · 1988 · European Journal of Pharmacology
148. Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats
     P.M Piffar, Ricardo Fernández, Osvaldo Tchaikovski et al. · 2003 · Cancer Letters
149. Comparative effects of β2-adrenergic agonists on muscle waste associated with tumour growth
     Neus Carbó, Joaquín López‐Soriano, Teresa Tarragó, Olga González, Marta Llovera, Francisco Javier López-Soriano, Josep María Adell Argilés · 1997 · Cancer Letters
150. Emerging drugs for sarcopenia: age-related muscle wasting
     Gordon Stuart Lynch · 2004 · Expert Opinion on Emerging Drugs
151. Chronopharmacological study of acetylsalicylic acid in mice
     Shigehiro Ohdo, Nobuya Ogawa, Jian Guo Song · 1995 · European Journal of Pharmacology Environmental Toxicology and Pharmacology
152. Some pharmacodynamic aspects on long-acting β-adrenoceptor agonists
     Bertil Waldeck · 1996 · General Pharmacology The Vascular System
153. Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle
     T. G. McDaneld, K. Hannon, Diane E. Moody · 2006 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
154. Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres
     Yasuharu Oishi, K Imoto, Takehiro Ogata, K. Taniguchi, Hisami MATSUMOTO, Roland R. Roy · 2002 · Acta Physiologica Scandinavica
155. Muscle wasting associated with endotoxemia in the rat: Modification by the β2-adrenoceptor agonist clenbuterol
     J. J. Choo, M.A. Horan, R. A. Little · 1989 · Bioscience Reports
156. The role of reperfusion injury in occlusive intestinal ischemia of the neonate: Malonaldehyde-derived fluorescent products and correlation of histology
     Christina Czyrko, Carmen K. Steigman, Debra L. Turley, Henry R. Drott, Moritz M. Ziegler · 1991 · Journal of Surgical Research
157. Stimulation of cyclic AMP‐dependent protein kinase in rat atria by (–;)‐CGP 12177 through an atypical β‐adrenoceptor
     Alberto Julio Kaumann, James A. Lynham · 1997 · British Journal of Pharmacology
158. Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment
     Gordon Stuart Lynch, Richard T. Hinkle, John A. Faulkner · 2001 · Neuromuscular Disorders
159. Clenbuterol retards loss of motor function in motor neuron degeneration mice
     Richard J. Zeman · 2004 · Experimental Neurology
160. Effect of clenbuterol on growth, carcase and skeletal muscle characteristics in broiler chickens
     Ch. Rehfeldt, Ruthild Schadereit, Rosemarie Weikard, Karin Reichel · 1997 · British Poultry Science
161. Power Output of Fast and Slow Skeletal Muscles of MDX (Dystrophic) and Control Mice After Clenbuterol Treatment
     Gordon Stuart Lynch, Richard T. Hinkle, John A. Faulkner · 2000 · Experimental Physiology
162. Effect of aging on rat skeletal muscle beta-AR function in male Fischer 344 x brown Norway rats
     Lisa M. Larkin, Jeffrey B. Halter, Mark A. Supiano · 1996 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
163. Biotechnology of β-adrenergic receptors
     Arthur Donny Strosberg · 1990 · Molecular Neurobiology
164. Body composition of animals treated with partitioning agents: implications for human health
     Werner G. Bergen, Robert A. Merkel · 1991 · The FASEB Journal
165. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis
     Yang Dong Teng, Howard Choi, Wenzheng Huang · 2006 · Neuroscience Letters
166. β-Adrenoceptor signaling in regenerating skeletal muscle after β-agonist administration
     Felice Beitzel, Martin N. Sillence, Gordon Stuart Lynch · 2007 · American Journal of Physiology-Endocrinology and Metabolism
167. Dose‐dependent separation of the hypertrophic and myotoxic effects of the β2‐adrenergic receptor agonist clenbuterol in rat striated muscles
     Jatin G. Burniston, William Andrew Clark, Lip‐Bun Tan, David F. Goldspink · 2006 · Muscle & Nerve
168. Clenbuterol-induced muscle growth: investigation of possible mediation by insulin
     Mary Ann McElligott, Jean E. Mulder, L Y Chaung, A. Barreto · 1987 · American Journal of Physiology-Endocrinology and Metabolism
169. Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle
     Richard J. Zeman, Y. Zhang, Joseph D. Etlinger · 1994 · American Journal of Physiology-Cell Physiology
170. Does the β 2 -Agonist Clenbuterol Help to Maintain Myocardial Potential to Recover During Mechanical Unloading?
     Hiroshi Tsuneyoshi, Wnimunk Oriyanhan, Hideo Kanemitsu · 2005 · Circulation
171. Beneficial versus adverse effects of long‐term use of clenbuterol in mdx mice
     Esther E. Dupont‐Versteegden, Michael S. Katz, Roger McCarter · 1995 · Muscle & Nerve
172. Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles
     Véronique‐Aurélie Bricout, B. Serrurier, André Xavier Bigard · 2004 · Acta Physiologica Scandinavica
173. β2-Adrenergic activation increases glycogen synthesis in L6 skeletal muscle cells through a signalling pathway independent of cyclic AMP
     Daniel L. Yamamoto, Dana S. Hutchinson, Tore Bengtsson · 2006 · Diabetologia
174. Contractile properties of clenbuterol-treatedmdx muscle are enhanced by low-intensity swimming
     Alan Hayes, David A. Williams · 1997 · Journal of Applied Physiology
175. Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of β-adrenergic receptor agonists
     T. G. McDaneld, Deana L. Hancock, Diane E. Moody · 2004 · Physiological Genomics
176. The effect of salbutamol on skeletal muscle in chronic heart failure
     Derek Harrington, Tuan Peng Chua, Andrew J.S. Coats · 2000 · International Journal of Cardiology
177. α-Adrenergic receptors in rat skeletal muscle
     Stephen Rattigan, Geoffrey J. Appleby, Stephen J. Edwards · 1986 · Biochemical and Biophysical Research Communications
178. Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-α activity
     Alan A. Sneddon, Margaret I. Delday, C. A. Maltin · 2000 · American Journal of Physiology-Endocrinology and Metabolism
179. Activation of cAMP-dependent protein kinase without a corresponding increase in phosphorylase activity.
     Stanley L. Keely · 1977 · PubMed
180. Changes in contractile activation characteristics of rat fast and slow skeletal muscle fibres during regeneration
     Paul Gregorevic, David R. Plant, Nicole Stupka, Gordon Stuart Lynch · 2004 · The Journal of Physiology
181. Tackling Australia's future health problems: developing strategies to combat sarcopenia − age‐related muscle wasting and weakness
     Gordon Stuart Lynch · 2004 · Internal Medicine Journal
182. Alternative splicing generates isoforms of human neuron-derived orphan receptor-1 (NOR-1) mRNA
     Naganari Ohkura, Mikiko Ito, Toshihiko Tsukada · 1998 · Gene
183. Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses
     J. Daniel Harkins, William E. Woods, Andreas F. Lehner · 2001 · Journal of Veterinary Pharmacology and Therapeutics
184. YEAR‐LONG CLENBUTEROL TREATMENT OF MICE INCREASES MASS, BUT NOT SPECIFIC FORCE OR NORMALIZED POWER, OF SKELETAL MUSCLES
     Gordon Stuart Lynch, Richard T. Hinkle, John A. Faulkner · 1999 · Clinical and Experimental Pharmacology and Physiology
185. Positive inotropic stimulation
     Marc Léone, Jacques Alban se, Claude Martin · 2002 · Current Opinion in Critical Care
186. The biochemical effects of clenbuterol: with particular reference to taurine and muscle damage
     Catherine J. Waterfield, Minakshi Jairath, Daniel S. Asker · 1995 · European Journal of Pharmacology Environmental Toxicology and Pharmacology
187. Clenbuterol Increases Stroke Power and Contractile Speed of Skeletal Muscle for Cardiac Assist
     Mario Petrou, S. Clarke, K. Morrison · 1999 · Circulation
188. Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats
     Julien Pinto, Alessandra Folador, Sandro José Ribeiro Bonatto, Júlia Aikawa, Ricardo Key Yamazaki, Nathalia Pizato, Mirela Facin, Hans Grohs, Heloísa Helena Paro de Oliveira, Katya Naliwaiko et al. · 2004 · The Journal of Nutritional Biochemistry
189. Clenbuterol increases the expression of myogenin but not myoD in immobilized rat muscles
     Margaret I. Delday, C. A. Maltin · 1997 · American Journal of Physiology-Endocrinology and Metabolism
190. LONG‐TERM CLENBUTEROL ADMINISTRATION ALTERS THE ISOMETRIC CONTRACTILE PROPERTIES OF SKELETAL MUSCLE FROM NORMAL AND DYSTROPHIN‐DEFICIENT MDX MICE
     Alan Hayes, David A. Williams · 1994 · Clinical and Experimental Pharmacology and Physiology
191. Beta Adrenoceptor Agonists, Clenbuterol, and Isoproterenol Retard Denervation Atrophy in Rat Gastrocnemius Muscle: Use of 3-Methylhistidine as a Marker of Myofibrillar Degeneration.
     Sapna Agrawal, Pushpa Thakur, Surender S. Katoch · 2003 · The Japanese Journal of Physiology
192. Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells
     Véronique Pizon, Giuseppe Baldacci · 2000 · Oncogene
193. The metabolism of cyclic-3?-5?-adenosine monophosphate (cAMP) in diseased muscle
     Nicola Canal, Lodovico Frattola, Salvatore Smirne · 1975 · Journal of Neurology
194. Effects of the β2-agonist clenbuterol on respiratory and limb muscles of weaning rats
     B Polla, Vanda Cappelli, F. Morello · 2001 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
195. Cilomilast: Orally Active Selective Phosphodiesterase-4 Inhibitor for Treatment of Chronic Obstructive Pulmonary Disease
     Shaunta‘ D Martina, Maha S Ismail, Kimi S. Vesta · 2006 · Annals of Pharmacotherapy
196. Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle
     CAROL E. TORGAN, Garret J. Etgen, Joseph T. Brozinick · 1993 · Journal of Applied Physiology
197. Potential Mechanisms for Repartitioning of Growth by β-Adrenergic Agonists
     H. J. Mersmann · 1989 · Springer eBooks
198. Selective Coupling of G Protein βγ Complexes to Inhibition of Ca2+ Channels
     Marı́a A. Diversé-Pierluissi, William E. McIntire, Chang‐Seon Myung, Margaret A. Lindorfer, James C. Garrison, Michael F. Goy, Kathleen Dunlap · 2000 · Journal of Biological Chemistry
199. Effects of the cyclo‐oxygenase inhibitor, fenbufen, on clenbuterol‐induced hypertrophy of cardiac and skeletal muscle of rats
     Robert M. Palmer, Margaret I. Delday, D.N. McMillan · 1990 · British Journal of Pharmacology
200. Alteration of contractile force and mass in the senescent diaphragm with β2-agonist treatment
     Wesley N. Smith, Amie J. Dirks, Takao Sugiura, Susan Muller, Phillip J. Scarpace, Scott K. Powers · 2002 · Journal of Applied Physiology